Sagimet Biosciences
SGMT
SGMT
66 hedge funds and large institutions have $78.8M invested in Sagimet Biosciences in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 13 closing their positions.
Holders
66
Holders Change
+3
Holders Change %
+4.76%
% of All Funds
0.88%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
16
Increased
15
Reduced
20
Closed
13
Calls
$281K
Puts
$1.26M
Net Calls
-$983K
Net Calls Change
-$674K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$3.12M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$1.5M |
| 3 |
6CM
3
683 Capital Management
New York
|
$622K |
| 4 |
BCM
4
Bridgeway Capital Management
Houston,
Texas
|
$1.01M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$5.09M |
Top Sellers
| 1 |
1
Bank of America
Charlotte,
North Carolina
|
$67.7K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$3.35M |
| 3 |
BBA
3
Baker Bros. Advisors
New York
|
$4.29M |
| 4 |
IC
4
Ikarian Capital
Dallas,
Texas
|
$53.9K |
| 5 |
BOCH
5
Blue Owl Capital Holdings
New York
|
$5.96M |
